Harvard, Church Lab Broke Promise to NIH on Open Spatial Tech Licensing, Vizgen, NanoString Allege
Premium
As part of a lawsuit against 10x Genomics, Vizgen has alleged that Harvard improperly gave spinout ReadCoor an exclusive license to tech developed under an NIH grant.
Personalized Residual Disease Assays Show Promise to Overcome Liquid Biopsy Challenges in Sarcomas
Premium
New data presented at the ASCO annual meeting this week showed that tumor-informed assays could detect emerging recurrence ahead of imaging.
BabySeq Project Unearths Actionable Genetic Variants Impacting Infants, Parents
Researchers saw monogenic disease-related mutations in almost 11 percent of infants' genomes, prompting further testing and management, including for family members.
CMS Contractor Novitas Rescinds Coverage for Multiple Cancer Genetic Tests
Novitas reviewed, analyzed, and published literature for a variety of genetic oncology tests and highlighted several that it claims are not medically reasonable or necessary.
In addition to establishing local teams in Europe and China, the company recently inked distribution agreements for other markets across the world.